Protein digestion-derived peptides and the peripheral regulation of food intake

Frontiers in Endocrinology

Volumn 8, Issue APR, 2017, Pages

  Caron, Juliette ^a   Domenger, Dorothée ^a   Dhulster, Pascal ^a   Ravallec, Rozenn ^a   Cudennec, Benoit ^a  

^a Cité scientifique   (France)

Author keywords

Bioactive peptides; Dipeptidyl peptidase IV; Enteroendocrine cells; Food intake regulation; Gut hormones; Protein digestion

Indexed keywords

ALBUMIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CARBOHYDRATE; CHOLECYSTOKININ; DIPEPTIDYL PEPTIDASE IV; FATTY ACID; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; MICROBIAL ENZYME; OPIATE RECEPTOR; PEPTIDE; PROTEIN HYDROLYSATE; PROTEINASE;

BIOLOGICAL ACTIVITY; BRAIN; FOOD INTAKE; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYDROLYSIS; INTESTINAL AVAILABILITY; INTESTINE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTAKE; REVIEW; SATIETY;

EID: 85018310110     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2017.00085     Document Type: Review

References (117)

1. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest (2007) 117(1):13-23. doi: 10.1172/JCI30227
2. Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes (2008) 15(1):73-8. doi:10.1097/MED.0b013e3282f43a73
3. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature (2006) 443(7109):289-95. doi:10.1038/nature05026
4. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology (2007) 132(6):2116-30. doi:10.1053/j.gastro.2007.03.048
5. Moran TH, Dailey MJ. Gut peptides: targets for antiobesity drug development? Endocrinology (2009) 150(6):2526-30. doi:10.1210/en.2009-0003
6. Westerterp-Plantenga MS, Lemmens SG, Westerterp KR. Dietary protein-its role in satiety, energetics, weight loss and health. Br J Nutr (2012) 108(S2):S105-12. doi:10.1017/S0007114512002589
7. Bensaid A, Tome D, Gietzen D, Even P, Morens C, Gausseres N, et al. Protein is more potent than carbohydrate for reducing appetite in rats. Physiol Behav (2002) 75(4):577-82. doi:10.1016/S0031-9384(02)00646-7
8. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr (2003) 89(2):239-48. doi:10.1079/BJN2002760
9. Westerterp-Plantenga MS. Protein intake and energy balance. Regul Pept (2008) 149(1-3):67-9. doi:10.1016/j.regpep.2007.08.026
10. Layman DK, Boileau RA, Erickson DJ, Painter JE, Shiue H, Sather C, et al. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr (2003) 133(2):411-7.
11. Horner K, Drummond E, Brennan L. Bioavailability of milk protein-derived bioactive peptides: a glycaemic management perspective. Nutr Res Rev (2016) 29(1):91-101. doi:10.1017/S0954422416000032
12. Shi G, Leray V, Scarpignato C, Bentouimou N, Varannes S, Cherbut C, et al. Specific adaptation of gastric emptying to diets with differing protein content in the rat: is endogenous cholecystokinin implicated? Gut (1997) 41(5):612-8. doi:10.1136/gut.41.5.612
13. Nishi T, Hara H, Tomita F. Soybean β-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats. J Nutr (2003) 133(2):352-7.
14. Liddle RA, Green GM, Conrad CK, Williams JA. Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am J Physiol (1986) 251(2 Pt 1):G243-8.
15. Brennan IM, Luscombe-Marsh ND, Seimon RV, Otto B, Horowitz M, Wishart JM, et al. Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men. Am J Physiol Gastrointest Liver Physiol (2012) 303(1):G129-40. doi:10.1152/ajpgi.00478.2011
16. Sharara A, Bouras EP, Misukonis M, Liddle RA. Evidence for indirect dietary regulation of cholecystokinin release in rats. Am J Physiol (1993) 265(1):G107-12.
17. Pupovac J, Anderson GH. Dietary peptides induce satiety via cholecystokinin-A and peripheral opioid receptors in rats. J Nutr (2002) 132(9):2775-80.
18. Nishi T, Hara H, Hira T, Tomita F. Dietary protein peptic hydrolysates stimulate cholecystokinin release via direct sensing by rat intestinal mucosal cells. Exp Biol Med (2001) 226(11):1031-6. doi:10.1177/153537020122601110
19. Cudennec B, Ravallec-Plé R, Courois E, Fouchereau-Peron M. Peptides from fish and crustacean by-products hydrolysates stimulate cholecystokinin release in STC-1 cells. Food Chem (2008) 111(4):970-5. doi:10.1016/j.foodchem.2008.05.016
20. Cudennec B, Fouchereau-Peron M, Ferry F, Duclos E, Ravallec R. In vitro and in vivo evidence for a satiating effect of fish protein hydrolysate obtained from blue whiting (Micromesistius poutassou) muscle. J Funct Foods (2012) 4(1):271-7. doi:10.1016/j.jff.2011.12.003
21. Cordier-Bussat M, Bernard C, Haouche S, Roche C, Abello J, Chayvialle JA, et al. Peptones stimulate cholecystokinin secretion and gene transcription in the intestinal cell line STC-1. Endocrinology (1997) 138(3):1137-44. doi:10.1210/endo.138.3.5023
22. Geraedts MC, Troost FJ, Fischer MA, Edens L, Saris WH. Direct induction of CCK and GLP-1 release from murine endocrine cells by intact dietary proteins. Mol Nutr Food Res (2011) 55(3):476-84. doi:10.1002/mnfr.201000142
23. Nishi T, Hara H, Asano K, Tomita F. The soybean β-conglycinin β 51-63 fragment suppresses appetite by stimulating cholecystokinin release in rats. J Nutr (2003) 133(8):2537-42.
24. Sufian MK, Hira T, Miyashita K, Nishi T, Asano K, Hara H. Pork peptone stimulates cholecystokinin secretion from enteroendocrine cells and suppresses appetite in rats. Biosci Biotechnol Biochem (2006) 70(8):1869-74. doi:10.1271/bbb.60046
25. Wang Y, Prpic V, Green GM, Reeve JR Jr, Liddle RA. Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC-1 cells. Am J Physiol Gastrointest Liver Physiol (2002) 282(1):G16-22.
26. Spannagel AW, Green GM, Guan D, Liddle RA, Faull K, Reeve JR. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci U S A (1996) 93(9):4415-20. doi:10.1073/pnas.93.9.4415
27. Tarasova N, Spannagel AW, Green GM, Gomez G, Reed JT, Thompson JC, et al. Distribution and localization of a novel cholecystokinin-releasing factor in the rat gastrointestinal tract 1. Endocrinology (1997) 138(12):5550-4. doi:10.1210/endo.138.12.5554
28. Miyasaka K, Guan D, Liddle RA, Green GM. Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide. Am J Physiol (1989) 257(2):G175-81.
29. Spannagel AW, Reeve JR Jr, Greeley GH Jr, Yanaihara N, Liddle RA, Green GM. Bioactivity of intraduodenally and intravenously infused fragments of luminal cholecystokinin releasing factor (LCRF). Regul Pept (1998) 73(3):161-4. doi:10.1016/S0167-0115(97)01074-4
30. Némoz-Gaillard E, Bernard C, Abello J, Cordier-Bussat M, Chayvialle JA, Cuber JC. Regulation of cholecystokinin secretion by peptones and peptidomimetic antibiotics in STC-1 cells. Endocrinology (1998) 139(3):932-8. doi:10.1210/en.139.3.932
31. Yoshida H, Tsunoda Y, Owyang C. Diazepam-binding inhibitor33-50 elicits Ca2+ oscillation and CCK secretion in STC-1 cells via L-type Ca2+ channels. Am J Physiol Gastrointest Liver Physiol (1999) 276(3):G694-702.
32. Choi S, Lee M, Shiu AL, Yo SJ, Aponte GW. Identification of a protein hydrolysate responsive G protein-coupled receptor in enterocytes. Am J Physiol Gastrointest Liver Physiol (2007) 292(1):G98-112. doi:10.1152/ajpgi.00295.2006
33. Choi S, Lee M, Shiu AL, Yo SJ, Hallden G, Aponte GW. GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells. Am J Physiol Gastrointest Liver Physiol (2007) 292(5):G1366-75. doi:10.1152/ajpgi.00516.2006
34. Conigrave AD, Hampson DR. Broad-spectrum amino acid-sensing class C G-protein coupled receptors: molecular mechanisms, physiological significance and options for drug development. Pharmacol Ther (2010) 127(3):252-60. doi:10.1016/j.pharmthera.2010.04.007
35. Conigrave A, Mun H-C, Brennan SC. Physiological significance of L-amino acid sensing by extracellular Ca2+-sensing receptors. Biochem Soc Trans (2007) 35(5):1195-8. doi:10.1042/BST0351195
36. Mangel AW, Prpic V, Wong H, Basavappa S, Hurst LJ, Scott L, et al. Phenylalanine-stimulated secretion of cholecystokinin is calcium dependent. Am J Physiol (1995) 268(1 Pt 1):G90-4.
37. Hira T, Nakajima S, Eto Y, Hara H. Calcium-sensing receptor mediates phenylalanine-induced cholecystokinin secretion in enteroendocrine STC-1 cells. FEBS J (2008) 275(18):4620-6. doi:10.1111/j.1742-4658.2008.06604.x
38. Nakajima S, Hira T, Eto Y, Asano K, Hara H. Soybean β51-63 peptide stimulates cholecystokinin secretion via a calcium-sensing receptor in enteroendocrine STC-1 cells. Regul Pept (2010) 159(1-3):148-55. doi:10.1016/j.regpep.2009.11.007
39. Nakajima S, Hira T, Hara H. Calcium-sensing receptor mediates dietary peptide-induced CCK secretion in enteroendocrine STC-1 cells. Mol Nutr Food Res (2012) 56(5):753-60. doi:10.1002/mnfr.201100666
40. Gevrey JC, Cordier-Bussat M, Nemoz-Gaillard E, Chayvialle JA, Abello J. Co-requirement of cyclic AMP-and calcium-dependent protein kinases for transcriptional activation of cholecystokinin gene by protein hydrolysates. J Biol Chem (2002) 277(25):22407-13. doi:10.1074/jbc.M201624200
41. Saxena M, Williams S, Taskén K, Mustelin T. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol (1999) 1(5):305-10. doi:10.1038/13024
42. Zanassi P, Paolillo M, Feliciello A, Avvedimento EV, Gallo V, Schinelli S. cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J Biol Chem (2001) 276(15):11487-95. doi:10.1074/jbc.M007631200
43. Alleaume C, Eychène A, Caigneaux E, Muller J-M, Philippe M. Vasoactive intestinal peptide stimulates proliferation in HT29 human colonic adenocarcinoma cells: concomitant activation of Ras/Rap1-B-Raf-ERK signalling pathway. Neuropeptides (2003) 37(2):98-104. doi:10.1016/S0143-4179(03)00020-9
44. Reidelberger RD, Heimann D, Kelsey L, Hulce M. Effects of peripheral CCK receptor blockade on feeding responses to duodenal nutrient infusions in rats. Am J Physiol Regul Integr Comp Physiol (2003) 284(2):R389-98. doi:10.1152/ajpregu.00529.2002
45. Raybould HE, Zittel TT, Holzer HH, Lloyd KK, Meyer JH. Gastroduodenal sensory mechanisms and CCK in inhibition of gastric emptying in response to a meal. Dig Dis Sci (1994) 39(12):41S-3S. doi:10.1007/BF02300368
46. Darcel NP, Liou AP, Tome D, Raybould HE. Activation of vagal afferents in the rat duodenum by protein digests requires PepT1. J Nutr (2005) 135(6):1491-5.
47. Liou AP, Chavez DI, Espero E, Hao S, Wank SA, Raybould HE. Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is indirectly mediated by the intestinal oligopeptide transporter PepT1. Am J Physiol Gastrointest Liver Physiol (2011) 300(5):G895-902. doi:10.1152/ajpgi.00521.2010
48. Matsumura K, Miki T, Jhomori T, Gonoi T, Seino S. Possible role of PEPT1 in gastrointestinal hormone secretion. Biochem Biophys Res Commun (2005) 336(4):1028-32. doi:10.1016/j.bbrc.2005.08.259
49. Staljanssens D, Van Camp J, Billiet A, De Meyer T, Al Shukor N, De Vos WH, et al. Screening of soy and milk protein hydrolysates for their ability to activate the CCK1 receptor. Peptides (2012) 34(1):226-31. doi:10.1016/j.peptides.2011.11.019
50. Foltz M, Ansems P, Schwarz J, Tasker MC, Lourbakos A, Gerhardt CC. Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonists of the CCK1 receptor. J Agric Food Chem (2008) 56(3):837-43. doi:10.1021/jf072611h
51. Ripken D, Van der Wielen N, Van der Meulen J, Schuurman T, Witkamp R, Hendriks H, et al. Cholecystokinin regulates satiation independently of the abdominal vagal nerve in a pig model of total subdiaphragmatic vagotomy. Physiol Behav (2015) 139:167-76. doi:10.1016/j.physbeh.2014.11.031
52. Meek CL, Lewis HB, Reimann F, Gribble FM, Park AJ. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides (2016) 77:28-37. doi:10.1016/j.peptides.2015.08.013
53. Hutchison AT, Feinle-Bisset C, Fitzgerald PC, Standfield S, Horowitz M, Clifton PM, et al. Comparative effects of intraduodenal whey protein hydrolysate on antropyloroduodenal motility, gut hormones, glycemia, appetite, and energy intake in lean and obese men. Am J Clin Nutr (2015) 102(6):1323-31. doi:10.3945/ajcn.115.114538
54. Stringer DM, Taylor CG, Appah P, Blewett H, Zahradka P. Consumption of buckwheat modulates the post-prandial response of selected gastrointestinal satiety hormones in individuals with type 2 diabetes mellitus. Metabolism (2013) 62(7):1021-31. doi:10.1016/j.metabol.2013.01.021
55. Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, et al. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care (2009) 32(9):1600-2. doi:10.2337/dc09-0723
56. Lejeune MP, Westerterp KR, Adam TC, Luscombe-Marsh ND, Westerterp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr (2006) 83(1):89-94.
57. Diepvens K, Häberer D, Westerterp-Plantenga M. Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans. Int J Obes (2008) 32(3):510-8. doi:10.1038/sj.ijo.0803758
58. Mochida T, Hira T, Hara H. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology (2010) 151(7):3095-104. doi:10.1210/en.2009-1510
59. Hsieh C-H, Wang T-Y, Hung C-C, Chen M, Hsu K. Improvement of glycemic control in streptozotocin-induced diabetic rats by Atlantic salmon skin gelatin hydrolysate as the dipeptidyl-peptidase IV inhibitor. Food Funct (2015) 6(6):1887-92. doi:10.1039/c5fo00124b
60. Ishikawa Y, Hira T, Inoue D, Harada Y, Hashimoto H, Fujii M, et al. Rice protein hydrolysates stimulate GLP-1 secretion, reduce GLP-1 degradation, and lower the glycemic response in rats. Food Funct (2015) 6(8):2525-34. doi:10.1039/c4fo01054j
61. Power-Grant O, Bruen C, Brennan L, Giblin L, Jakeman P, FitzGerald R. In vitro bioactive properties of intact and enzymatically hydrolysed whey protein: targeting the enteroinsular axis. Food Funct (2015) 6(3):972-80. doi:10.1039/c4fo00983e
62. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol (1993) 138(1):159-66. doi:10.1677/joe.0.1380159
63. Klaauw AA, Keogh JM, Henning E, Trowse VM, Dhillo WS, Ghatei MA, et al. High protein intake stimulates postprandial GLP1 and PYY release. Obesity (2013) 21(8):1602-7. doi:10.1002/oby.20154
64. Dougkas A, östman E. Protein-enriched liquid preloads varying in macronutrient content modulate appetite and appetite-regulating hormones in healthy adults. J Nutr (2016) 146(3):637-45. doi:10.3945/jn.115.217224
65. Herrmann C, Göke R, Richter G, Fehmann H-C, Arnold R, Göke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion (1995) 56(2):117-26. doi:10.1159/000201231
66. Hira T, Mochida T, Miyashita K, Hara H. GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats. Am J Physiol Gastrointest Liver Physiol (2009) 297(4):G663-71. doi:10.1152/ajpgi.90635.2008
67. Cordier-Bussat M, Bernard C, Levenez F, Klages N, Laser-Ritz B, Philippe J, et al. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes (1998) 47(7):1038-45. doi:10.2337/diabetes.47.7.1038
68. Reimer RA, Darimont C, Gremlich S, Nicolas-Metral V, Ruegg UT, Mace K. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology (2001) 142(10):4522-8. doi:10.1210/endo.142.10.8415
69. Reimann F, Williams L, da Silva Xavier G, Rutter G, Gribble F. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia (2004) 47(9):1592-601. doi:10.1007/s00125-004-1498-0
70. Tolhurst G, Zheng Y, Parker HE, Habib AM, Reimann F, Gribble FM. Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP. Endocrinology (2011) 152(2):405-13. doi:10.1210/en.2010-0956
71. Meek CL, Lewis HB, Vergese B, Park A, Reimann F, Gribble F. The effect of encapsulated glutamine on gut peptide secretion in human volunteers. Peptides (2016) 77:38-46. doi:10.1016/j.peptides.2015.10.008
72. Mace OJ, Schindler M, Patel S. The regulation of K-and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. J Physiol (2012) 590(12):2917-36. doi:10.1113/jphysiol.2011.223800
73. Oya M, Kitaguchi T, Pais R, Reimann F, Gribble F, Tsuboi T. The G protein-coupled receptor family C group 6 subtype A (GPRC6A) receptor is involved in amino acid-induced glucagon-like peptide-1 secretion from GLUTag cells. J Biol Chem (2013) 288(7):4513-21. doi:10.1074/jbc.M112.402677
74. Le Nevé B, Daniel H. Selected tetrapeptides lead to a GLP-1 release from the human enteroendocrine cell line NCI-H716. Regul Pept (2011) 167(1):14-20. doi:10.1016/j.regpep.2010.10.010
75. Diakogiannaki E, Pais R, Tolhurst G, Parker HE, Horscroft J, Rauscher B, et al. Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia (2013) 56(12):2688-96. doi:10.1007/s00125-013-3037-3
76. Pais R, Gribble FM, Reimann F. Signalling pathways involved in the detection of peptones by murine small intestinal enteroendocrine L-cells. Peptides (2016) 77:9-15. doi:10.1016/j.peptides.2015.07.019
77. Reimer RA. Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. J Endocrinol (2006) 191(1):159-70. doi:10.1677/joe.1.06557
78. Caron J, Domenger D, Belguesmia Y, Kouach M, Lesage J, Goossens J-F, et al. Protein digestion and energy homeostasis: how generated peptides may impact intestinal hormones? Food Res Intern (2016) 88(Pt B):310-8. doi:10.1016/j.foodres.2015.12.018
79. Gevrey JC, Malapel M, Philippe J, Mithieux G, Chayvialle JA, Abello J, et al. Protein hydrolysates stimulate proglucagon gene transcription in intestinal endocrine cells via two elements related to cyclic AMP response element. Diabetologia (2004) 47(5):926-36. doi:10.1007/s00125-004-1380-0
80. Caron J, Cudennec B, Domenger D, Belguesmia Y, Flahaut C, Kouach M, et al. Simulated GI digestion of dietary protein: release of new bioactive peptides involved in gut hormone secretion. Food Res Intern (2016) 89:382-90. doi:10.1016/j.foodres.2016.08.033
81. Jao C-L, Hung C-C, Tung Y-S, Lin P-Y, Chen M-C, Hsu K-C. The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes. Biomedicine (2015) 5(3):1-7. doi:10.7603/s40681-015-0014-9
82. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet (2006) 368(9548):1696-705. doi:10.1016/S0140-6736(06)69705-5
83. Mulvihill EE, Drucker DJ. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr Rev (2014) 35(6):992-1019. doi:10.1210/er.2014-1035
84. Godinho R, Mega C, Teixeira-de-Lemos E, Carvalho E, Teixeira F, Fernandes R, et al. The place of dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapeutics: a "me too" or "the special one" Antidiabetic class? J Diabetes Res (2015) 2015:28. doi:10.1155/2015/806979
85. Lacroix IME, Li-Chan ECY. Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int Dairy J (2012) 25(2):97-102. doi:10.1016/j.idairyj.2012.01.003
86. Kopf-Bolanz KA, Schwander F, Gijs M, Vergères G, Portmann R, Egger L. Impact of milk processing on the generation of peptides during digestion. Int Dairy J (2014) 35(2):130-8. doi:10.1016/j.idairyj.2013.10.012
87. Guo L, Harnedy PA, Zhang L, Li B, Zhang Z, Hou H, et al. In vitro assessment of the multifunctional bioactive potential of Alaska pollock skin collagen following simulated gastrointestinal digestion. J Sci Food Agric (2015) 95(7):1514-20. doi:10.1002/jsfa.6854
88. Li-Chan EC, Hunag S-L, Jao C-L, Ho K-P, Hsu K-C. Peptides derived from Atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors. J Agric Food Chem (2012) 60(4):973-8. doi:10.1021/jf204720q
89. Velarde-Salcedo AJ, Barrera-Pacheco A, Lara-González S, Montero-Morán GM, Díaz-Gois A, de Mejia EG, et al. In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins. Food Chem (2013) 136(2):758-64. doi:10.1016/j.foodchem.2012.08.032
90. De Souza Rocha T, Hernandez LMR, Chang YK, de Mejía EG. Impact of germination and enzymatic hydrolysis of cowpea bean (Vigna unguiculata) on the generation of peptides capable of inhibiting dipeptidyl peptidase IV. Food Res Intern (2014) 64:799-809. doi:10.1016/j.foodres.2014.08.016
91. Cudennec B, Balti R, Ravallec R, Caron J, Bougatef A, Dhulster P, et al. In vitro evidence for gut hormone stimulation release and dipeptidyl-peptidase IV inhibitory activity of protein hydrolysate obtained from cuttlefish (Sepia officinalis) viscera. Food Res Intern (2015) 78:238-45. doi:10.1016/j.foodres.2015.10.003
92. Nongonierma A, FitzGerald R. Investigation of the potential of hemp, pea, rice and soy protein hydrolysates as a source of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. Food Dig Res Curr Opin (2015) 6:19-29. doi:10.1007/s13228-015-0039-2
93. Nongonierma AB, FitzGerald RJ. Dipeptidyl peptidase IV inhibitory properties of a whey protein hydrolysate: influence of fractionation, stability to simulated gastrointestinal digestion and food-drug interaction. Int Dairy J (2013) 32(1):33-9. doi:10.1016/j.idairyj.2013.03.005
94. Jin Y, Yu Y, Qi Y, Wang F, Yan J, Zou H. Peptide profiling and the bioactivity character of yogurt in the simulated gastrointestinal digestion. J Proteomics (2016) 141:24-46. doi:10.1016/j.jprot.2016.04.010
95. Harnedy PA, O'Keeffe MB, FitzGerald RJ. Purification and identification of dipeptidyl peptidase (DPP) IV inhibitory peptides from the macroalga Palmaria palmata. Food Chem (2015) 172(0):400-6. doi:10.1016/j.foodchem.2014.09.083
96. Nongonierma AB, FitzGerald RJ. Prospects for the management of type 2 diabetes using food protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity. Curr Opin Food Sci (2016) 8:19-24. doi:10.1016/j.cofs.2016.01.007
97. Huang S-L, Jao C-L, Ho K-P, Hsu K-C. Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates. Peptides (2012) 35(1):114-21. doi:10.1016/j.peptides.2012.03.006
98. Dave LA, Hayes M, Mora L, Montoya CA, Moughan PJ, Rutherfurd SM. Gastrointestinal endogenous protein-derived bioactive peptides: an in vitro study of their gut modulatory potential. Int J Mol Sci (2016) 17(4):482. doi:10.3390/ijms17040482
99. Dave LA, Hayes M, Moughan PJ, Rutherfurd SM. Novel dipeptidyl peptidase IV inhibitory and antioxidant peptides derived from human gastrointestinal endogenous proteins. Int J Pept Res Ther (2016) 22(3):355-69. doi:10.1007/s10989-016-9515-y
100. Huang S-L, Hung C-C, Jao C-L, Tung Y-S, Hsu K-C. Porcine skin gelatin hydrolysate as a dipeptidyl peptidase IV inhibitor improves glycemic control in streptozotocin-induced diabetic rats. J Funct Foods (2014) 11(0):235-42. doi:10.1016/j.jff.2014.09.010
101. Wang Y, Landheer S, van Gilst WH, van Amerongen A, Hammes H-P, Henning RH, et al. Attenuation of renovascular damage in Zucker diabetic fatty rat by NWT-03, an egg protein hydrolysate with ACE-and DPP4-inhibitory Activity. PLoS One (2012) 7(10):e46781. doi:10.1371/journal.pone.0046781
102. Uenishi H, Kabuki T, Seto Y, Serizawa A, Nakajima H. Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from gouda-type cheese and its effect on plasma glucose in rats. Int Dairy J (2012) 22(1):24-30. doi:10.1016/j.idairyj.2011.08.002
103. Ochiai M, Kuroda T, Matsuo T. Increased muscular triglyceride content and hyperglycemia in Goto-Kakizaki rat are decreased by egg white hydrolysate. Int J Food Sci Nutr (2014) 65(4):495-501. doi:10.3109/09637486.2013.879288
104. Janssen P, Pottel H, Vos R, Tack J. Endogenously released opioids mediate meal-induced gastric relaxation via peripheral mu-opioid receptors. Aliment Pharmacol Ther (2011) 33(5):607-14. doi:10.1111/j.1365-2036.2010.04557.x
105. Froetschel M, Azain M, Edwards G, Barb C, Amos H. Opioid and cholecystokinin antagonists alleviate gastric inhibition of food intake by premeal loads of casein in meal-fed rats. J Nutr (2001) 131(12):3270-6.
106. Duraffourd C, De Vadder F, Goncalves D, Delaere F, Penhoat A, Brusset B, et al. Mu-opioid receptors and dietary protein stimulate a gut-brain neural circuitry limiting food intake. Cell (2012) 150(2):377-88. doi:10.1016/j.cell.2012.05.039
107. Pfluger PT, Schriever SC, Tschöp MH. Nutropioids, hedonism in the gut? Cell Metab (2012) 16(2):137-9. doi:10.1016/j.cmet.2012.07.011
108. Mithieux G, Misery P, Magnan C, Pillot B, Gautier-Stein A, Bernard C, et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab (2005) 2(5):321-9. doi:10.1016/j.cmet.2005.09.010
109. De Vadder F, Gautier-Stein A, Mithieux G. [Opioid receptors associated with portal vein regulate a gut-brain neural circuitry limiting food intake]. Med Sci (Paris) (2013) 29(1):31-3. doi:10.1051/medsci/2013291010
110. De Vadder F, Gautier-Stein A, Mithieux G. Satiety and the role of μ-opioid receptors in the portal vein. Curr Opin Pharmacol (2013) 13(6):959-63. doi:10.1016/j.coph.2013.09.003
111. Mithieux G. Crosstalk between gastrointestinal neurons and the brain in the control of food intake. Best Pract Res Clin Endocrinol Metab (2014) 28(5):739-44. doi:10.1016/j.beem.2014.03.004
112. Mithieux G. Nutropioids regulate gut-brain circuitry controlling food intake. In: Delhanty PJD, van der Lely AJ, editors. How Gut and Brain Control Metabolism. Karger Publishers (2014). p. 155-62.
113. Mithieux G. Metabolic effects of portal vein sensing. Diabetes Obes Metab (2014) 16(S1):56-60. doi:10.1111/dom.12338
114. Teschemacher H. Opioid receptor ligands derived from food proteins. Curr Pharm Des (2003) 9(16):1331-44. doi:10.2174/1381612033454856
115. Westerterp-Plantenga M, Luscombe-Marsh N, Lejeune M, Diepvens K, Nieuwenhuizen A, Engelen M, et al. Dietary protein, metabolism, and body-weight regulation: dose-response effects. Int J Obes (2006) 30:S16-23. doi:10.1038/sj.ijo.0803487
116. Watford M. Is the small intestine a gluconeogenic organ? Nutr Rev (2005) 63(10):356-60. doi:10.1111/j.1753-4887.2005.tb00114.x
117. L'Heureux-Bouron D, Tomé D, Rampin O, Even PC, Larue-Achagiotis C, Fromentin G. Total subdiaphragmatic vagotomy does not suppress high protein diet-induced food intake depression in rats. J Nutr (2003) 133(8):2639-42.